Free Trial
→ URGENT: Someone's Moving Gold Out of London... (From Golden Portfolio) (Ad) Buy EFX Stock  Free EFX Stock Alerts

Equifax (EFX) Financials

Equifax logo
$261.55 -0.59 (-0.22%)
As of 02:56 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.
Compare
Annual Income Statements for Equifax

Annual Income Statements for Equifax

This table shows Equifax's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015
Period end date 12/31/2024 12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019 12/31/2018 12/31/2017 12/31/2016 12/31/2015
Net Income / (Loss) Attributable to Common Shareholders		 604 545 696 744 520 -384 311 587 489 429
Consolidated Net Income / (Loss)		 607 552 700 749 526 -378 317 598 495 435
Net Income / (Loss) Continuing Operations		 607 552 700 749 526 -378 317 598 495 435
Total Pre-Tax Income 		811 718 930 949 685 -414 370 747 728 637
Total Revenue		 5,452 5,024 4,939 4,778 -142 3,396 3,309 3,269 -92 2,600
Net Interest Income / (Expense)		 -229 -241 -183 -146 -142 -112 -104 -93 -92 -64
Total Interest Income		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Interest Expense		 229 241 183 146 142 112 104 93 92 64
Long-Term Debt Interest Expense		 229 241 183 146 142 112 104 93 92 64
Total Non-Interest Income		 5,681 5,265 5,122 4,924 0.00 3,508 3,412 3,362 0.00 2,664
Other Non-Interest Income		 5,681 5,265 5,122 4,924 - 3,508 3,412 3,362 - 2,664
Total Non-Interest Expense		 4,639 4,332 4,066 3,786 -827 3,843 2,964 2,531 -820 1,970
Property & Liability Insurance Claims		 2,519 2,335 2,177 1,981 - 1,522 - 1,211 - -
Other Operating Expenses		 1,451 1,386 1,329 1,325 3,060 1,990 2,654 1,032 2,054 1,772
Depreciation Expense		 670 611 560 480 391 331 310 288 265 198
Nonoperating Income / (Expense), net		 -2.50 26 57 -43 - 33 26 7.70 - 6.50
Income Tax Expense		 203 166 230 201 159 -36 53 149 233 202
Net Income / (Loss) Attributable to Noncontrolling Interest		 3.20 6.40 4.00 4.30 6.10 6.00 6.50 11 6.30 5.70
Basic Earnings per Share		 $4.88 $4.44 $5.69 $6.11 $4.28 ($3.18) $2.58 $4.89 $4.10 $3.61
Weighted Average Basic Shares Outstanding		 123.80M 122.90M 122.40M 121.90M 121.50M 120.90M 120.40M 120.10M 119.30M 118.70M
Diluted Earnings per Share		 $4.84 $4.40 $5.65 $6.02 $4.24 ($3.15) $2.56 $4.83 $4.04 $3.55
Weighted Average Diluted Shares Outstanding		 124.90M 123.90M 123.30M 123.60M 122.80M 122M 121.40M 121.50M 121.10M 120.90M
Weighted Average Basic & Diluted Shares Outstanding		 124.02M 123.96M 122.49M 122.08M 121.79M 120.80M 120.40M 120.10M 119.20M 118.90M
Cash Dividends to Common per Share		 $1.56 $1.56 $1.56 $1.56 $1.56 $1.56 $1.56 $1.56 $1.32 $1.16

Quarterly Income Statements for Equifax

This table shows Equifax's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022
Period end date 3/31/2025 12/31/2024 9/30/2024 6/30/2024 3/31/2024 12/31/2023 9/30/2023 6/30/2023 3/31/2023 12/31/2022 9/30/2022
Net Income / (Loss) Attributable to Common Shareholders		 133 174 141 164 125 132 162 138 112 108 166
Consolidated Net Income / (Loss)		 134 173 143 165 126 135 164 139 114 109 167
Net Income / (Loss) Continuing Operations		 134 173 143 165 126 135 164 139 114 109 167
Total Pre-Tax Income 		185 226 194 225 167 183 191 192 152 141 220
Total Revenue		 1,389 1,364 1,386 1,373 1,330 1,266 1,256 1,257 1,244 1,143 1,197
Net Interest Income / (Expense)		 -53 -56 -56 -57 -60 -60 -63 -61 -58 -55 -47
Total Interest Income		 0.00 - 0.00 0.00 0.00 - 0.00 0.00 0.00 - 0.00
Total Interest Expense		 53 56 56 57 60 60 63 61 58 55 47
Long-Term Debt Interest Expense		 53 56 56 57 60 60 63 61 58 55 47
Total Non-Interest Income		 1,442 1,419 1,442 1,431 1,389 1,327 1,319 1,318 1,302 1,198 1,244
Other Non-Interest Income		 1,442 1,419 1,442 1,431 1,389 1,327 1,319 1,318 1,302 1,198 1,244
Total Non-Interest Expense		 1,206 1,131 1,195 1,148 1,165 1,082 1,073 1,081 1,097 1,022 1,001
Property & Liability Insurance Claims		 657 - 645 - 628 - 585 - 580 539 543
Other Operating Expenses		 375 -286 380 984 373 -245 333 931 366 340 318
Depreciation Expense		 175 172 169 165 164 157 154 150 150 142 141
Nonoperating Income / (Expense), net		 2.50 -6.80 3.00 -0.30 1.60 -1.70 7.10 16 4.40 20 24
Income Tax Expense		 52 52 51 59 41 48 26 53 39 32 53
Net Income / (Loss) Attributable to Noncontrolling Interest		 0.70 -0.70 1.40 1.30 1.20 2.10 2.10 1.10 1.10 1.00 1.20
Basic Earnings per Share		 $1.07 $1.41 $1.14 $1.32 $1.01 $1.07 $1.32 $1.13 $0.92 $0.88 $1.35
Weighted Average Basic Shares Outstanding		 124.10M 123.80M 123.90M 123.70M 123.50M 122.90M 123M 122.70M 122.60M 122.40M 122.40M
Diluted Earnings per Share		 $1.06 $1.40 $1.13 $1.31 $1.00 $1.06 $1.31 $1.12 $0.91 $0.88 $1.34
Weighted Average Diluted Shares Outstanding		 125.10M 124.90M 125.20M 124.80M 124.80M 123.90M 123.90M 123.80M 123.50M 123.30M 123.30M
Weighted Average Basic & Diluted Shares Outstanding		 124.20M 124.02M 123.95M 123.74M 123.61M 123.96M 123.22M 122.72M 122.64M 122.49M 122.44M
Cash Dividends to Common per Share		 $0.39 $0.39 $0.39 $0.39 $0.39 $0.39 $0.39 $0.39 $0.39 $0.39 $0.39

Annual Cash Flow Statements for Equifax

This table details how cash moves in and out of Equifax's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015
Period end date 12/31/2024 12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019 12/31/2018 12/31/2017 12/31/2016 12/31/2015
Net Change in Cash & Equivalents		 -47 -68 61 -1,460 1,283 178 -113 207 36 -35
Net Cash From Operating Activities		 1,325 1,117 757 1,335 946 314 672 816 823 769
Net Cash From Continuing Operating Activities		 1,325 1,123 757 1,335 946 314 672 816 823 769
Net Income / (Loss) Continuing Operations		 607 552 700 749 526 -378 317 598 495 435
Consolidated Net Income / (Loss)		 607 552 700 749 526 -378 317 598 495 435
Depreciation Expense		 681 620 569 490 399 337 316 291 269 200
Non-Cash Adjustments to Reconcile Net Income		 15 -12 114 123 -28 -33 43 -5.80 -12 -5.50
Changes in Operating Assets and Liabilities, net		 22 -36 -626 -26 49 388 -3.20 -67 71 140
Net Cash From Investing Activities		 -512 -878 -960 -3,398 -493 -698 -462 -350 -1,976 -148
Net Cash From Continuing Investing Activities		 -512 -878 -960 -3,398 -493 -698 -462 -350 -1,976 -148
Purchase of Investment Securities		 -512 -284 -1,058 -3,405 -493 -698 -6.90 -358 -1,976 -151
Divestitures		 0.00 6.90 99 1.50 0.00 0.00 - - - 2.90
Net Cash From Financing Activities		 -846 -306 274 618 811 558 -311 -264 1,160 -639
Net Cash From Continuing Financing Activities		 -846 -306 274 618 811 558 -311 -264 1,160 -639
Issuance of Debt		 650 873 992 1,697 1,123 998 995 352 1,575 0.00
Repayment of Debt		 -1,360 -957 -506 -791 -136 -257 -1,067 -323 -283 -336
Payment of Dividends		 -198 -237 -194 -197 -194 -195 -198 -196 -163 -144
Other Financing Activities, Net		 61 15 -17 -22 17 12 -40 -20 32 37
Effect of Exchange Rate Changes		 -14 -0.80 -11 -14 19 3.50 -13 4.30 29 -17

Quarterly Cash Flow Statements for Equifax

This table details how cash moves in and out of Equifax's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022
Period end date 3/31/2025 12/31/2024 9/30/2024 6/30/2024 3/31/2024 12/31/2023 9/30/2023 6/30/2023 3/31/2023 12/31/2022 9/30/2022
Net Change in Cash & Equivalents		 25 -298 286 -19 -16 -196 249 -68 -53 44 18
Net Cash From Operating Activities		 224 325 480 268 253 322 382 262 151 325 355
Net Cash From Continuing Operating Activities		 224 325 480 268 253 328 382 262 151 325 355
Net Income / (Loss) Continuing Operations		 134 173 143 165 126 135 164 139 114 109 167
Consolidated Net Income / (Loss)		 134 173 143 165 126 135 164 139 114 109 167
Depreciation Expense		 176 174 173 167 167 159 157 152 152 145 143
Non-Cash Adjustments to Reconcile Net Income		 31 -12 6.00 -2.60 23 8.20 -53 8.30 25 36 17
Changes in Operating Assets and Liabilities, net		 -117 -10 157 -62 -63 27 114 -38 -140 36 28
Net Cash From Investing Activities		 -107 -119 -124 -137 -132 -154 -406 -156 -163 -152 -478
Net Cash From Continuing Investing Activities		 -107 -119 -124 -137 -132 -154 -406 -156 -163 -152 -478
Purchase of Investment Securities		 -107 -119 -124 -137 -132 448 -406 -163 -163 -152 -479
Net Cash From Financing Activities		 -96 -501 -64 -149 -132 -370 281 -174 -43 -143 152
Net Cash From Continuing Financing Activities		 -96 -501 -64 -149 -132 -370 281 -174 -43 -143 152
Repayment of Debt		 -48 -463 -694 -115 -88 -292 327 -831 -161 -501 -5.40
Payment of Dividends		 -49 -49 -49 -51 -49 -91 -49 -50 -48 -48 -48
Other Financing Activities, Net		 0.80 10 29 18 4.50 13 2.10 8.90 -9.30 16 -0.70
Effect of Exchange Rate Changes		 4.40 -2.80 -4.90 -1.10 -4.70 5.30 -7.90 -0.50 2.30 13 -9.90

Annual Balance Sheets for Equifax

This table presents Equifax's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015
Period end date 12/31/2024 12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019 12/31/2018 12/31/2017 12/31/2016 12/31/2015
Total Assets		 11,759 12,280 11,548 11,041 9,612 7,909 7,153 7,233 6,664 4,502
Cash and Due from Banks		 170 217 285 225 1,685 401 224 336 129 93
Loans and Leases, Net of Allowance		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Premises and Equipment, Net		 1,892 1,834 1,587 1,316 -235 948 81 139 160 154
Goodwill		 6,548 6,830 6,384 6,258 4,496 4,308 4,130 4,184 3,974 2,571
Intangible Assets		 1,616 1,954 1,913 1,993 2,467 1,140 1,878 1,770 1,726 1,135
Other Assets		 1,534 1,446 1,379 1,249 1,199 1,112 841 804 675 548
Total Liabilities & Shareholders' Equity		 11,759 12,280 11,548 11,041 9,612 7,909 7,153 7,233 6,664 4,502
Total Liabilities		 6,840 7,593 7,575 7,440 6,402 5,286 3,998 3,994 3,943 2,151
Short-Term Debt		 826 1,161 1,218 1,036 1,260 151 181 1,076 666 90
Accrued Interest Payable		 251 245 229 238 252 164 213 161 149 113
Other Short-Term Payables		 735 613 568 1,017 971 1,044 433 329 444 401
Long-Term Debt		 4,323 4,748 4,820 4,470 3,277 3,380 2,631 1,739 2,087 1,138
Other Long-Term Liabilities		 706 826 739 678 641 548 540 690 596 409
Commitments & Contingencies		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Redeemable Noncontrolling Interest		 105 135 0.00 - - - - - - -
Total Equity & Noncontrolling Interests		 4,814 4,552 3,973 3,601 3,210 2,623 3,156 3,239 2,721 2,350
Total Preferred & Common Equity		 4,797 4,534 3,957 3,584 3,168 2,579 3,108 3,174 2,663 2,311
Preferred Stock		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Common Equity		 4,797 4,534 3,957 3,584 3,168 2,579 3,108 3,174 2,663 2,311
Common Stock		 2,146 1,992 1,825 1,767 1,701 1,636 1,587 1,563 1,544 1,491
Retained Earnings		 6,019 5,609 5,256 4,752 4,185 3,855 4,718 4,601 4,153 3,834
Treasury Stock		 -2,645 -2,635 -2,651 -2,639 -2,547 -2,557 -2,571 -2,578 -2,506 -2,530
Accumulated Other Comprehensive Income / (Loss)		 -723 -431 -474 -295 -171 -354 -626 -412 -529 -485
Noncontrolling Interest		 18 18 17 17 42 44 48 65 59 40

Quarterly Balance Sheets for Equifax

This table presents Equifax's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022
Period end date 3/31/2025 12/31/2024 9/30/2024 6/30/2024 3/31/2024 12/31/2023 9/30/2023 6/30/2023 3/31/2023 12/31/2022 9/30/2022
Total Assets		 11,855 11,759 12,344 12,152 12,251 12,280 12,349 11,538 11,584 11,548 11,308
Cash and Due from Banks		 195 170 468 182 201 217 413 164 233 285 242
Loans and Leases, Net of Allowance		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Premises and Equipment, Net		 -974 1,892 -874 -813 -746 1,834 -665 -629 -570 1,587 -498
Goodwill		 6,591 6,548 6,730 6,747 6,761 6,830 6,731 6,401 6,396 6,384 6,304
Intangible Assets		 4,432 1,616 4,517 4,483 4,464 1,954 4,427 4,145 4,080 1,913 3,938
Other Assets		 1,611 1,534 1,503 1,554 1,571 1,446 1,443 1,457 1,446 1,379 1,323
Total Liabilities & Shareholders' Equity		 11,855 11,759 12,344 12,152 12,251 12,280 12,349 11,538 11,584 11,548 11,308
Total Liabilities		 6,742 6,840 7,298 7,319 7,539 7,593 7,864 7,330 7,502 7,575 7,532
Short-Term Debt		 812 826 903 972 1,078 1,161 692 317 962 1,218 1,236
Accrued Interest Payable		 281 251 263 238 306 245 267 271 283 229 222
Other Short-Term Payables		 638 735 708 577 590 613 623 504 548 568 561
Long-Term Debt		 4,324 4,323 4,721 4,743 4,745 4,748 5,500 5,503 4,988 4,820 4,819
Other Long-Term Liabilities		 687 706 702 789 820 826 782 734 722 739 695
Commitments & Contingencies		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Redeemable Noncontrolling Interest		 113 105 121 121 132 135 176 - - 0.00 -
Total Equity & Noncontrolling Interests		 5,000 4,814 4,926 4,713 4,581 4,552 4,309 4,208 4,082 3,973 3,776
Total Preferred & Common Equity		 4,981 4,797 4,909 4,696 4,562 4,534 4,293 4,191 4,064 3,957 3,759
Preferred Stock		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Common Equity		 4,981 4,797 4,909 4,696 4,562 4,534 4,293 4,191 4,064 3,957 3,759
Common Stock		 2,184 2,146 2,128 2,088 2,055 1,992 1,967 1,881 1,862 1,825 1,811
Retained Earnings		 6,103 6,019 5,893 5,800 5,685 5,609 5,525 5,411 5,320 5,256 5,196
Treasury Stock		 -2,648 -2,645 -2,647 -2,648 -2,652 -2,635 -2,635 -2,655 -2,657 -2,651 -2,651
Accumulated Other Comprehensive Income / (Loss)		 -657 -723 -465 -544 -527 -431 -564 -446 -461 -474 -596
Noncontrolling Interest		 19 18 17 17 19 18 16 17 18 17 17

Annual Metrics And Ratios for Equifax

This table displays calculated financial ratios and metrics derived from Equifax's official financial filings.

Metric 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015
Period end date 12/31/2024 12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019 12/31/2018 12/31/2017 12/31/2016 12/31/2015
Growth Metrics		 - - - - - - - - - -
Revenue Growth		 8.52% 1.71% 3.37% 3,474.51% -104.17% 2.64% 1.20% 3,649.84% -103.54% 9.80%
EBITDA Growth		 13.84% -8.99% -2.73% 36.65% 1,087.70% -116.63% -35.87% 3.30% 20.09% 7.28%
EBIT Growth		 17.45% -20.71% -12.03% 44.83% 253.25% -229.78% -53.38% 1.47% 15.57% 10.62%
NOPAT Growth		 14.52% -19.09% -15.98% 48.72% 268.13% -206.15% -50.18% 19.54% 15.04% 16.00%
Net Income Growth		 10.08% -21.21% -6.45% 42.25% 239.17% -219.27% -46.99% 20.78% 13.87% 16.26%
EPS Growth		 10.00% -22.12% -6.15% 41.98% 234.60% -223.05% -47.00% 19.55% 13.80% 19.53%
Operating Cash Flow Growth		 18.60% 47.51% -43.28% 41.07% 201.53% -53.32% -17.62% -0.85% 7.01% 24.81%
Free Cash Flow Firm Growth		 2,247.63% 78.49% 57.36% 45.93% -113.62% -231.02% 2,896.52% 100.91% -321.40% 61.02%
Invested Capital Growth		 -4.98% 5.84% 9.92% 17.55% 25.90% 3.13% -1.43% 10.58% 52.97% -5.35%
Revenue Q/Q Growth		 1.82% 2.51% -1.42% 822.99% -103.75% 2.03% -33.92% 303.60% -103.15% 1.67%
EBITDA Q/Q Growth		 4.37% 6.27% -5.41% -2.53% 34.92% 5.18% -17.89% -1.14% 4.75% 1.59%
EBIT Q/Q Growth		 6.23% 10.03% -9.55% -6.51% 63.10% -0.43% -30.38% -1.70% 3.04% 2.34%
NOPAT Q/Q Growth		 7.52% 8.67% -11.63% 11.30% 67.54% -0.43% -33.90% 7.94% 2.44% 2.32%
Net Income Q/Q Growth		 6.83% 4.83% -1.96% 6.46% 11.01% -3.28% -30.18% 9.06% 2.44% 3.38%
EPS Q/Q Growth		 7.56% 4.27% -1.74% 6.55% 10.42% -2.94% -30.43% 9.03% 2.54% 3.50%
Operating Cash Flow Q/Q Growth		 0.20% -0.29% -7.33% 7.07% 7.56% 26.58% -5.95% -8.06% 5.99% 3.99%
Free Cash Flow Firm Q/Q Growth		 98.71% 85.15% -287.90% 42.88% 17.12% -150.89% -1.45% -95.28% 9.60% -14.24%
Invested Capital Q/Q Growth		 -5.65% -0.75% 1.84% -1.19% 3.25% 4.28% -0.78% 1.66% -3.56% -1.78%
Profitability Metrics		 - - - - - - - - - -
EBITDA Margin		 27.40% 26.12% 29.19% 31.02% 0.00% -3.23% 19.96% 31.50% 0.00% 31.93%
EBIT Margin		 14.91% 13.78% 17.67% 20.77% 0.00% -13.17% 10.41% 22.60% 0.00% 24.24%
Profit (Net Income) Margin		 11.14% 10.98% 14.18% 15.66% 0.00% -11.13% 9.58% 18.29% 0.00% 16.72%
Tax Burden Percent		 74.93% 76.85% 75.31% 78.86% 76.80% 91.37% 85.58% 80.10% 67.99% 68.30%
Interest Burden Percent		 99.69% 103.71% 106.49% 95.65% 100.00% 92.55% 107.52% 101.04% 100.00% 101.03%
Effective Tax Rate		 25.07% 23.15% 24.69% 21.14% 23.20% 0.00% 14.42% 19.90% 32.01% 31.70%
Return on Invested Capital (ROIC)		 5.90% 5.16% 6.88% 9.29% 0.00% -5.16% 4.91% 10.27% 0.00% 11.70%
ROIC Less NNEP Spread (ROIC-NNEP)		 5.86% 5.49% 7.62% 8.61% 0.00% -7.22% 5.69% 10.49% 0.00% 12.02%
Return on Net Nonoperating Assets (RNNOA)		 6.75% 7.58% 11.61% 12.69% 0.00% -7.92% 5.01% 9.80% 0.00% 7.27%
Return on Equity (ROE)		 12.64% 12.74% 18.49% 21.98% 18.04% -13.09% 9.91% 20.07% 19.52% 18.97%
Cash Return on Invested Capital (CROIC)		 11.01% -0.51% -2.58% -6.85% -15.36% -8.25% 6.35% 0.22% -30.94% 17.19%
Operating Return on Assets (OROA)		 6.76% 5.81% 7.73% 9.61% 0.00% -5.94% 4.79% 10.63% 0.00% 13.75%
Return on Assets (ROA)		 5.05% 4.63% 6.20% 7.25% 0.00% -5.02% 4.41% 8.61% 0.00% 9.49%
Return on Common Equity (ROCE)		 12.28% 12.49% 18.41% 21.79% 17.77% -12.88% 9.74% 19.65% 19.15% 18.66%
Return on Equity Simple (ROE_SIMPLE)		 12.66% 12.17% 17.70% 20.88% 16.61% -14.66% 10.20% 18.84% 18.59% 18.82%
Net Operating Profit after Tax (NOPAT)		 609 532 657 783 526 -313 295 592 495 430
NOPAT Margin		 11.17% 10.59% 13.31% 16.38% 0.00% -9.22% 8.91% 18.10% 0.00% 16.55%
Net Nonoperating Expense Percent (NNEP)		 0.03% -0.33% -0.74% 0.68% 0.00% 2.05% -0.79% -0.22% 0.00% -0.32%
SG&A Expenses to Revenue		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Expenses to Revenue		 85.09% 86.22% 82.33% 79.23% 0.00% 113.17% 89.59% 77.40% 0.00% 75.76%
Earnings before Interest and Taxes (EBIT)		 813 692 873 992 685 -447 345 739 728 630
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)		 1,494 1,312 1,442 1,482 1,085 -110 660 1,030 997 830
Valuation Ratios		 - - - - - - - - - -
Price to Book Value (P/BV)		 6.59 6.68 5.93 9.78 7.22 6.35 3.45 4.20 4.94 5.25
Price to Tangible Book Value (P/TBV)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Price to Revenue (P/Rev)		 5.79 6.03 4.75 7.34 0.00 4.82 3.24 4.08 0.00 4.67
Price to Earnings (P/E)		 52.29 55.55 33.73 47.12 43.98 0.00 34.50 22.69 26.94 28.28
Dividend Yield		 0.61% 0.63% 0.81% 0.54% 0.83% 1.15% 1.76% 1.41% 1.20% 1.13%
Earnings Yield		 1.91% 1.80% 2.96% 2.12% 2.27% 0.00% 2.90% 4.41% 3.71% 3.54%
Enterprise Value to Invested Capital (EV/IC)		 3.64 3.41 2.92 4.43 3.33 3.18 2.24 2.62 2.90 3.72
Enterprise Value to Revenue (EV/Rev)		 6.73 7.19 5.92 8.45 0.00 5.76 4.03 4.85 0.00 5.12
Enterprise Value to EBITDA (EV/EBITDA)		 24.57 27.54 20.29 27.24 23.76 0.00 20.21 15.41 15.90 16.03
Enterprise Value to EBIT (EV/EBIT)		 45.13 52.20 33.51 40.68 37.61 0.00 38.74 21.48 21.76 21.12
Enterprise Value to NOPAT (EV/NOPAT)		 60.23 67.93 44.49 51.58 48.98 0.00 45.27 26.81 32.01 30.92
Enterprise Value to Operating Cash Flow (EV/OCF)		 27.70 32.36 38.64 30.24 27.24 62.32 19.85 19.45 19.26 17.30
Enterprise Value to Free Cash Flow (EV/FCFF)		 32.26 0.00 0.00 0.00 0.00 0.00 34.98 1,246.36 0.00 21.03
Leverage & Solvency		 - - - - - - - - - -
Debt to Equity		 1.05 1.26 1.52 1.53 1.41 1.35 0.89 0.87 1.01 0.52
Long-Term Debt to Equity		 0.88 1.01 1.21 1.24 1.02 1.29 0.83 0.54 0.77 0.48
Financial Leverage		 1.15 1.38 1.52 1.47 1.38 1.10 0.88 0.93 0.79 0.61
Leverage Ratio		 2.50 2.75 2.98 3.03 3.00 2.61 2.25 2.33 2.20 2.00
Compound Leverage Factor		 2.49 2.85 3.18 2.90 3.00 2.41 2.42 2.36 2.20 2.02
Debt to Total Capital		 51.14% 55.76% 60.31% 60.46% 58.57% 57.38% 47.11% 46.49% 50.29% 34.32%
Short-Term Debt to Total Capital		 8.20% 10.96% 12.17% 11.38% 16.27% 2.46% 3.03% 17.77% 12.17% 2.51%
Long-Term Debt to Total Capital		 42.93% 44.81% 48.15% 49.08% 42.30% 54.92% 44.09% 28.73% 38.12% 31.81%
Preferred Equity to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital		 1.22% 1.45% 0.17% 0.18% 0.54% 0.72% 0.80% 1.07% 1.07% 1.10%
Common Equity to Total Capital		 47.64% 42.79% 39.52% 39.36% 40.89% 41.90% 52.08% 52.44% 48.64% 64.57%
Debt to EBITDA		 3.45 4.50 4.19 3.72 4.18 -32.16 4.26 2.73 2.76 1.48
Net Debt to EBITDA		 3.33 4.34 3.99 3.56 2.63 -28.50 3.92 2.41 2.63 1.37
Long-Term Debt to EBITDA		 2.89 3.62 3.34 3.02 3.02 -30.78 3.98 1.69 2.09 1.37
Debt to NOPAT		 8.45 11.11 9.18 7.04 8.62 -11.28 9.53 4.76 5.56 2.85
Net Debt to NOPAT		 8.17 10.70 8.75 6.75 5.42 -10.00 8.78 4.19 5.30 2.64
Long-Term Debt to NOPAT		 7.10 8.93 7.33 5.71 6.23 -10.80 8.92 2.94 4.21 2.65
Noncontrolling Interest Sharing Ratio		 2.87% 1.97% 0.44% 0.86% 1.48% 1.60% 1.76% 2.07% 1.93% 1.61%
Liquidity Ratios		 - - - - - - - - - -
Cash Flow Metrics		 - - - - - - - - - -
Free Cash Flow to Firm (FCFF)		 1,137 -53 -246 -577 -1,068 -500 382 13 -1,401 633
Operating Cash Flow to CapEx		 0.00% 185.73% 0.00% 0.00% 0.00% 0.00% 208.82% 0.00% 0.00% 0.00%
Free Cash Flow to Firm to Interest Expense		 4.96 -0.22 -1.35 -3.97 -7.54 -4.48 3.69 0.14 -15.21 9.92
Operating Cash Flow to Interest Expense		 5.78 4.63 4.14 9.17 6.68 2.81 6.49 8.79 8.94 12.05
Operating Cash Flow Less CapEx to Interest Expense		 5.78 2.14 4.14 9.17 6.68 2.81 3.38 8.79 8.94 12.05
Efficiency Ratios		 - - - - - - - - - -
Asset Turnover		 0.45 0.42 0.44 0.46 0.00 0.45 0.46 0.47 0.00 0.57
Fixed Asset Turnover		 2.93 2.94 3.40 0.00 0.00 6.60 30.11 21.87 0.00 26.31
Capital & Investment Metrics		 - - - - - - - - - -
Invested Capital		 10,068 10,596 10,011 9,108 7,748 6,154 5,967 6,054 5,475 3,579
Invested Capital Turnover		 0.53 0.49 0.52 0.57 0.00 0.56 0.55 0.57 0.00 0.71
Increase / (Decrease) in Invested Capital		 -528 585 904 1,360 1,594 187 -87 579 1,896 -202
Enterprise Value (EV)		 36,691 36,135 29,251 40,367 25,771 19,556 13,346 15,869 15,848 13,308
Market Capitalization		 31,589 30,290 23,481 35,068 22,877 16,383 10,711 13,327 13,166 12,133
Book Value per Share		 $38.70 $36.80 $32.31 $29.38 $26.05 $21.30 $25.77 $26.44 $22.23 $19.51
Tangible Book Value per Share		 ($27.16) ($34.49) ($35.45) ($38.25) ($31.19) ($23.70) ($24.05) ($23.15) ($25.36) ($11.78)
Total Capital		 10,068 10,596 10,011 9,108 7,748 6,154 5,967 6,054 5,475 3,579
Total Debt		 5,149 5,909 6,038 5,507 4,538 3,531 2,811 2,815 2,753 1,228
Total Long-Term Debt		 4,323 4,748 4,820 4,470 3,277 3,380 2,631 1,739 2,087 1,138
Net Debt		 4,979 5,692 5,753 5,282 2,853 3,130 2,588 2,478 2,624 1,135
Capital Expenditures (CapEx)		 0.00 601 0.00 0.00 0.00 0.00 322 0.00 0.00 0.00
Net Nonoperating Expense (NNE)		 1.87 -20 -43 34 0.00 65 -22 -6.17 0.00 -4.44
Net Nonoperating Obligations (NNO)		 5,149 5,909 6,038 5,507 4,538 3,531 2,811 2,815 2,753 1,228
Total Depreciation and Amortization (D&A)		 681 620 569 490 399 337 316 291 269 200
Earnings Adjustments		 - - - - - - - - - -
Adjusted Basic Earnings per Share		 $4.88 $4.44 $5.69 $6.11 $4.28 ($3.30) $2.49 $4.89 $4.10 $3.61
Adjusted Weighted Average Basic Shares Outstanding		 123.80M 122.90M 122.40M 121.90M 121.50M 120.90M 120.40M 120.10M 119.30M 118.70M
Adjusted Diluted Earnings per Share		 $4.84 $4.40 $5.65 $6.02 $4.24 ($3.27) $2.47 $4.83 $4.04 $3.55
Adjusted Weighted Average Diluted Shares Outstanding		 124.90M 123.90M 123.30M 123.60M 122.80M 122M 121.40M 121.50M 121.10M 120.90M
Adjusted Basic & Diluted Earnings per Share		 $0.00 $0.00 $0.00 $0.00 $0.00 ($3.30) $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding		 124.02M 123.96M 122.49M 122.08M 121.79M 121.24M 120.70M 120.12M 119.85M 118.71M
Normalized Net Operating Profit after Tax (NOPAT)		 609 532 657 783 -2,759 -313 295 592 -1,640 430
Normalized NOPAT Margin		 11.17% 10.59% 13.31% 16.38% 0.00% -9.22% 8.91% 18.10% 0.00% 16.55%
Pre Tax Income Margin		 14.87% 14.29% 18.82% 19.86% 0.00% -12.19% 11.20% 22.84% 0.00% 24.49%
Debt Service Ratios		 - - - - - - - - - -
EBIT to Interest Expense		 3.55 2.87 4.77 6.82 4.84 -4.00 3.33 7.96 7.91 9.88
NOPAT to Interest Expense		 2.66 2.20 3.59 5.37 3.72 -2.80 2.85 6.38 5.38 6.75
EBIT Less CapEx to Interest Expense		 3.55 0.38 4.77 6.82 4.84 -4.00 0.22 7.96 7.91 9.88
NOPAT Less CapEx to Interest Expense		 2.66 -0.29 3.59 5.37 3.72 -2.80 -0.26 6.38 5.38 6.75
Payout Ratios		 - - - - - - - - - -
Dividend Payout Ratio		 32.57% 43.03% 27.73% 26.25% 36.89% -51.65% 62.52% 32.74% 33.00% 33.16%
Augmented Payout Ratio		 32.57% 43.03% 27.73% 35.59% 36.89% -51.65% 62.52% 45.64% 33.00% 78.31%

Quarterly Metrics And Ratios for Equifax

This table displays calculated financial ratios and metrics derived from Equifax's official financial filings.

Metric Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022
Period end date 3/31/2025 12/31/2024 9/30/2024 6/30/2024 3/31/2024 12/31/2023 9/30/2023 6/30/2023 3/31/2023 12/31/2022 9/30/2022
Growth Metrics		 - - - - - - - - - - -
Revenue Growth		 4.47% 7.69% 10.28% 9.25% 6.85% 10.74% 4.94% -1.43% -5.98% -5.87% 0.78%
EBITDA Growth		 8.35% 18.23% 7.02% 19.34% 10.53% 29.10% 0.47% -18.92% -30.56% -23.65% -5.05%
EBIT Growth		 10.85% 25.84% 3.92% 27.64% 11.64% 51.93% -6.23% -33.00% -49.50% -43.14% -17.80%
NOPAT Growth		 5.69% 31.51% -11.18% 29.37% 13.31% 44.81% 6.35% -36.08% -48.65% -50.75% -19.78%
Net Income Growth		 6.11% 28.85% -13.15% 18.51% 11.10% 23.28% -1.56% -30.78% -49.06% -11.37% -19.22%
EPS Growth		 6.00% 32.08% -13.74% 16.96% 9.89% 20.45% -2.24% -31.29% -49.44% -10.20% -19.28%
Operating Cash Flow Growth		 -11.40% 0.84% 25.62% 2.06% 67.46% -1.01% 7.55% -4.79% 176.02% -15.55% -10.92%
Free Cash Flow Firm Growth		 210.44% 257.30% 121.25% -73.17% -448.00% 44.55% -48.18% 89.50% 96.00% 30.75% 69.63%
Invested Capital Growth		 -2.72% -4.98% -0.05% 5.18% 5.02% 5.84% 8.61% 3.42% 1.82% 9.92% 6.65%
Revenue Q/Q Growth		 1.87% -1.58% 0.90% 3.27% 5.02% 0.79% -0.05% 1.00% 8.83% -4.49% -6.11%
EBITDA Q/Q Growth		 -11.50% 11.48% -7.04% 18.15% -3.44% 0.91% 3.66% 9.43% 12.78% -21.46% -16.35%
EBIT Q/Q Growth		 -21.27% 21.75% -15.16% 36.30% -10.62% 0.54% 4.20% 19.22% 21.65% -37.95% -25.55%
NOPAT Q/Q Growth		 -26.06% 27.07% -15.07% 32.45% -8.00% -14.18% 23.71% 16.01% 17.57% -36.98% -25.64%
Net Income Q/Q Growth		 -22.79% 21.44% -13.62% 31.01% -6.25% -18.14% 17.86% 22.82% 4.03% -34.63% -17.13%
EPS Q/Q Growth		 -24.29% 23.89% -13.74% 31.00% -5.66% -19.08% 16.96% 23.08% 3.41% -34.33% -17.79%
Operating Cash Flow Q/Q Growth		 -31.07% -32.26% 79.25% 5.86% -21.55% -15.61% 45.63% 73.69% -53.63% -8.31% 28.91%
Free Cash Flow Firm Q/Q Growth		 -40.74% 383.29% 141.33% 6.71% 15.59% 34.71% -236.82% -195.22% 91.46% -74.46% 76.13%
Invested Capital Q/Q Growth		 1.79% -5.65% 1.17% 0.12% -0.57% -0.75% 6.46% -0.03% 0.20% 1.84% 1.38%
Profitability Metrics		 - - - - - - - - - - -
EBITDA Margin		 25.87% 29.77% 26.29% 28.53% 24.94% 27.12% 27.09% 26.12% 24.11% 23.26% 28.29%
EBIT Margin		 13.17% 17.04% 13.77% 16.38% 12.41% 14.58% 14.61% 14.02% 11.88% 10.63% 16.35%
Profit (Net Income) Margin		 9.63% 12.71% 10.30% 12.03% 9.48% 10.62% 13.08% 11.09% 9.12% 9.54% 13.94%
Tax Burden Percent		 72.17% 76.85% 73.63% 73.55% 75.69% 73.54% 86.16% 72.57% 74.57% 77.16% 75.97%
Interest Burden Percent		 101.37% 97.07% 101.57% 99.87% 100.97% 99.08% 103.87% 109.02% 102.98% 116.38% 112.21%
Effective Tax Rate		 27.83% 23.15% 26.37% 26.45% 24.31% 26.46% 13.84% 27.43% 25.43% 22.84% 24.03%
Return on Invested Capital (ROIC)		 5.04% 6.91% 5.09% 6.12% 4.67% 5.23% 6.02% 4.99% 4.33% 4.24% 6.54%
ROIC Less NNEP Spread (ROIC-NNEP)		 5.07% 6.81% 5.12% 6.11% 4.69% 5.21% 6.12% 5.19% 4.38% 4.50% 6.85%
Return on Net Nonoperating Assets (RNNOA)		 5.66% 7.84% 6.35% 7.80% 6.27% 7.18% 9.07% 7.56% 6.61% 6.86% 10.94%
Return on Equity (ROE)		 10.70% 14.75% 11.44% 13.92% 10.94% 12.41% 15.09% 12.56% 10.93% 11.10% 17.48%
Cash Return on Invested Capital (CROIC)		 8.69% 11.01% 5.36% 0.64% 0.41% -0.51% -3.48% 1.51% 3.76% -2.58% 1.38%
Operating Return on Assets (OROA)		 6.02% 7.73% 5.97% 7.23% 5.32% 6.15% 6.06% 5.96% 5.02% 4.65% 7.32%
Return on Assets (ROA)		 4.40% 5.76% 4.47% 5.31% 4.07% 4.48% 5.42% 4.72% 3.86% 4.17% 6.24%
Return on Common Equity (ROCE)		 10.39% 14.33% 11.04% 13.68% 10.73% 12.17% 14.71% 12.50% 10.89% 11.05% 17.40%
Return on Equity Simple (ROE_SIMPLE)		 12.35% 0.00% 11.58% 12.57% 12.37% 0.00% 12.26% 12.62% 14.54% 0.00% 19.00%
Net Operating Profit after Tax (NOPAT)		 132 179 140 165 125 136 158 128 110 94 149
NOPAT Margin		 9.50% 13.09% 10.14% 12.05% 9.39% 10.72% 12.59% 10.17% 8.86% 8.20% 12.42%
Net Nonoperating Expense Percent (NNEP)		 -0.03% 0.09% -0.04% 0.00% -0.02% 0.02% -0.10% -0.20% -0.05% -0.27% -0.31%
SG&A Expenses to Revenue		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Expenses to Revenue		 86.83% 82.96% 86.23% 83.62% 87.59% 85.42% 85.39% 85.98% 88.12% 89.37% 83.65%
Earnings before Interest and Taxes (EBIT)		 183 232 191 225 165 185 184 176 148 122 196
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)		 359 406 364 392 332 343 340 328 300 266 339
Valuation Ratios		 - - - - - - - - - - -
Price to Book Value (P/BV)		 6.06 6.59 7.41 6.38 7.21 6.68 5.20 6.84 6.06 5.93 5.51
Price to Tangible Book Value (P/TBV)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Price to Revenue (P/Rev)		 5.48 5.79 6.79 5.74 6.44 6.03 4.56 5.92 5.07 4.75 4.14
Price to Earnings (P/E)		 49.33 52.29 64.64 51.37 59.00 55.55 42.88 54.64 41.97 33.73 29.18
Dividend Yield		 0.64% 0.61% 0.53% 0.64% 0.58% 0.63% 0.86% 0.67% 0.78% 0.81% 0.92%
Earnings Yield		 2.03% 1.91% 1.55% 1.95% 1.69% 1.80% 2.33% 1.83% 2.38% 2.96% 3.43%
Enterprise Value to Invested Capital (EV/IC)		 3.44 3.64 3.90 3.38 3.67 3.41 2.65 3.42 3.03 2.92 2.70
Enterprise Value to Revenue (EV/Rev)		 6.40 6.73 7.78 6.82 7.57 7.19 5.78 7.09 6.25 5.92 5.30
Enterprise Value to EBITDA (EV/EBITDA)		 23.19 24.57 29.11 25.33 28.79 27.54 22.93 27.85 23.19 20.29 17.42
Enterprise Value to EBIT (EV/EBIT)		 42.46 45.13 54.43 47.01 54.53 52.20 45.00 53.54 41.70 33.51 27.51
Enterprise Value to NOPAT (EV/NOPAT)		 57.26 60.23 73.52 60.93 70.76 67.93 57.84 71.40 54.92 44.49 35.69
Enterprise Value to Operating Cash Flow (EV/OCF)		 27.23 27.70 31.51 29.12 31.74 32.36 25.27 31.40 27.44 38.64 32.50
Enterprise Value to Free Cash Flow (EV/FCFF)		 39.07 32.26 72.79 541.40 906.91 0.00 0.00 230.83 81.29 0.00 202.63
Leverage & Solvency		 - - - - - - - - - - -
Debt to Equity		 1.00 1.05 1.11 1.18 1.24 1.26 1.38 1.38 1.46 1.52 1.60
Long-Term Debt to Equity		 0.85 0.88 0.94 0.98 1.01 1.01 1.23 1.31 1.22 1.21 1.28
Financial Leverage		 1.12 1.15 1.24 1.28 1.34 1.38 1.48 1.46 1.51 1.52 1.60
Leverage Ratio		 2.45 2.50 2.59 2.62 2.71 2.75 2.86 2.83 2.90 2.98 3.05
Compound Leverage Factor		 2.49 2.43 2.63 2.62 2.74 2.73 2.97 3.09 2.98 3.47 3.43
Debt to Total Capital		 50.12% 51.14% 52.71% 54.17% 55.27% 55.76% 58.00% 58.04% 59.31% 60.31% 61.59%
Short-Term Debt to Total Capital		 7.92% 8.20% 8.47% 9.21% 10.23% 10.96% 6.48% 3.16% 9.58% 12.17% 12.57%
Long-Term Debt to Total Capital		 42.19% 42.93% 44.24% 44.96% 45.04% 44.81% 51.52% 54.87% 49.72% 48.15% 49.02%
Preferred Equity to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital		 1.28% 1.22% 1.29% 1.30% 1.43% 1.45% 1.79% 0.17% 0.18% 0.17% 0.17%
Common Equity to Total Capital		 48.60% 47.64% 46.00% 44.52% 43.30% 42.79% 40.21% 41.79% 40.51% 39.52% 38.24%
Debt to EBITDA		 3.38 3.45 3.93 4.06 4.33 4.50 5.02 4.72 4.54 4.19 3.97
Net Debt to EBITDA		 3.25 3.33 3.60 3.93 4.18 4.34 4.68 4.59 4.37 3.99 3.81
Long-Term Debt to EBITDA		 2.84 2.89 3.30 3.37 3.53 3.62 4.46 4.46 3.81 3.34 3.16
Debt to NOPAT		 8.34 8.45 9.93 9.77 10.65 11.11 12.65 12.10 10.76 9.18 8.14
Net Debt to NOPAT		 8.02 8.17 9.10 9.46 10.29 10.70 11.81 11.76 10.34 8.75 7.81
Long-Term Debt to NOPAT		 7.02 7.10 8.33 8.11 8.68 8.93 11.24 11.44 9.02 7.33 6.48
Noncontrolling Interest Sharing Ratio		 2.86% 2.87% 3.45% 1.71% 1.91% 1.97% 2.52% 0.41% 0.44% 0.44% 0.44%
Liquidity Ratios		 - - - - - - - - - - -
Cash Flow Metrics		 - - - - - - - - - - -
Free Cash Flow to Firm (FCFF)		 419 707 146 -354 -379 -449 -688 -204 -69 -810 -464
Operating Cash Flow to CapEx		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Free Cash Flow to Firm to Interest Expense		 7.91 12.66 2.60 -6.17 -6.35 -7.45 -10.95 -3.36 -1.20 -14.83 -9.86
Operating Cash Flow to Interest Expense		 4.23 5.82 8.52 4.67 4.23 5.34 6.08 4.32 2.62 5.96 7.54
Operating Cash Flow Less CapEx to Interest Expense		 4.23 5.82 8.52 4.67 4.23 5.34 6.08 4.32 2.62 5.96 7.54
Efficiency Ratios		 - - - - - - - - - - -
Asset Turnover		 0.46 0.45 0.43 0.44 0.43 0.42 0.41 0.43 0.42 0.44 0.45
Fixed Asset Turnover		 0.00 2.93 0.00 0.00 0.00 2.94 0.00 0.00 0.00 3.40 0.00
Capital & Investment Metrics		 - - - - - - - - - - -
Invested Capital		 10,249 10,068 10,671 10,548 10,536 10,596 10,677 10,029 10,032 10,011 9,831
Invested Capital Turnover		 0.53 0.53 0.50 0.51 0.50 0.49 0.48 0.49 0.49 0.52 0.53
Increase / (Decrease) in Invested Capital		 -287 -528 -5.70 519 504 585 846 332 179 904 613
Enterprise Value (EV)		 35,280 36,691 41,655 35,641 38,683 36,135 28,310 34,334 30,364 29,251 26,551
Market Capitalization		 30,207 31,589 36,361 29,971 32,910 30,290 22,339 28,660 24,629 23,481 20,721
Book Value per Share		 $40.16 $38.70 $39.67 $37.99 $36.94 $36.80 $34.98 $34.17 $33.18 $32.31 $30.71
Tangible Book Value per Share		 ($48.71) ($27.16) ($51.22) ($52.86) ($53.96) ($34.49) ($55.94) ($51.82) ($52.35) ($35.45) ($52.96)
Total Capital		 10,249 10,068 10,671 10,548 10,536 10,596 10,677 10,029 10,032 10,011 9,831
Total Debt		 5,136 5,149 5,624 5,714 5,823 5,909 6,192 5,820 5,949 6,038 6,055
Total Long-Term Debt		 4,324 4,323 4,721 4,743 4,745 4,748 5,500 5,503 4,988 4,820 4,819
Net Debt		 4,941 4,979 5,156 5,532 5,622 5,692 5,780 5,656 5,717 5,753 5,813
Capital Expenditures (CapEx)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Net Nonoperating Expense (NNE)		 -1.80 5.23 -2.21 0.22 -1.21 1.25 -6.12 -12 -3.28 -15 -18
Net Nonoperating Obligations (NNO)		 5,136 5,149 5,624 5,714 5,823 5,909 6,192 5,820 5,949 6,038 6,055
Total Depreciation and Amortization (D&A)		 176 174 173 167 167 159 157 152 152 145 143
Earnings Adjustments		 - - - - - - - - - - -
Adjusted Basic Earnings per Share		 $1.07 $1.41 $1.14 $1.32 $1.01 $1.07 $1.32 $1.13 $0.92 $0.88 $1.35
Adjusted Weighted Average Basic Shares Outstanding		 124.10M 123.80M 123.90M 123.70M 123.50M 122.90M 123M 122.70M 122.60M 122.40M 122.40M
Adjusted Diluted Earnings per Share		 $1.06 $1.40 $1.13 $1.31 $1.00 $1.06 $1.31 $1.12 $0.91 $0.88 $1.34
Adjusted Weighted Average Diluted Shares Outstanding		 125.10M 124.90M 125.20M 124.80M 124.80M 123.90M 123.90M 123.80M 123.50M 123.30M 123.30M
Adjusted Basic & Diluted Earnings per Share		 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding		 124.20M 124.02M 123.95M 123.74M 123.61M 123.96M 123.22M 122.72M 122.64M 122.49M 122.44M
Normalized Net Operating Profit after Tax (NOPAT)		 132 179 140 165 125 136 158 128 110 94 149
Normalized NOPAT Margin		 9.50% 13.09% 10.14% 12.05% 9.39% 10.72% 12.59% 10.17% 8.86% 8.20% 12.42%
Pre Tax Income Margin		 13.35% 16.54% 13.99% 16.36% 12.53% 14.44% 15.18% 15.28% 12.23% 12.37% 18.35%
Debt Service Ratios		 - - - - - - - - - - -
EBIT to Interest Expense		 3.46 4.16 3.39 3.93 2.76 3.06 2.92 2.90 2.57 2.23 4.16
NOPAT to Interest Expense		 2.50 3.20 2.50 2.89 2.09 2.25 2.52 2.11 1.91 1.72 3.16
EBIT Less CapEx to Interest Expense		 3.46 4.16 3.39 3.93 2.76 3.06 2.92 2.90 2.57 2.23 4.16
NOPAT Less CapEx to Interest Expense		 2.50 3.20 2.50 2.89 2.09 2.25 2.52 2.11 1.91 1.72 3.16
Payout Ratios		 - - - - - - - - - - -
Dividend Payout Ratio		 32.15% 32.57% 42.23% 40.59% 42.19% 43.03% 37.03% 36.64% 32.78% 27.73% 27.05%
Augmented Payout Ratio		 32.15% 32.57% 42.23% 40.59% 42.19% 43.03% 37.03% 36.64% 32.78% 27.73% 27.05%

Frequently Asked Questions About Equifax's Financials

When does Equifax's financial year end?

According to the most recent income statement we have on file, Equifax's fiscal year ends in December. Their fiscal year 2024 ended on December 31, 2024.

How has Equifax's net income changed over the last 9 years?

Equifax's net income appears to be on an upward trend, with a most recent value of $607.30 million in 2024, rising from $434.80 million in 2015. The previous period was $551.70 million in 2023. See where experts think Equifax is headed by visiting Equifax's forecast page.

How has Equifax revenue changed over the last 9 years?

Over the last 9 years, Equifax's total revenue changed from $2.60 billion in 2015 to $5.45 billion in 2024, a change of 109.7%.

How much debt does Equifax have?

Equifax's total liabilities were at $6.84 billion at the end of 2024, a 9.9% decrease from 2023, and a 218.0% increase since 2015.

How much cash does Equifax have?

In the past 9 years, Equifax's cash and equivalents has ranged from $93.30 million in 2015 to $1.68 billion in 2020, and is currently $169.90 million as of their latest financial filing in 2024.

How has Equifax's book value per share changed over the last 9 years?

Over the last 9 years, Equifax's book value per share changed from 19.51 in 2015 to 38.70 in 2024, a change of 98.4%.


Related Companies

This page (NYSE:EFX) was last updated on 5/29/2025 by MarketBeat.com Staff
From Our Partners
Market Panic: Trump Just Dropped a Bomb on Your Stocks
tock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...
American Alternative | Sponsored
July 2025 Rule Change to Impact Retirement Investors
There's a massive change from a new rule going into effect this July. And it's one the Big Banks are alread...
Premier Gold Co | Sponsored
White House to reset Social Security?
Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...
Altimetry | Sponsored
Is President Trump Lying To You With This?
President Trump’s economic transition isn’t without hardship. But what if there were a smart, tax-free way to ...
Colonial Metals | Sponsored
A grave, grave error.
I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...
Porter & Company | Sponsored
Silicon Valley Gold Rush
A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...
Stansberry Research | Sponsored
Buffett’s favorite chart just hit 209% – here’s what that means for gold
A Historic Gold Announcement Is About to Rock Wall Street For months, sharp-eyed analysts have watched the ...
Golden Portfolio | Sponsored
Trump Exec Order 14179 is wealth “gift” to good Americans?
Is President Trump’s Executive Order 14179… A secret way to restore wealth for good citizens? If you’ve ...
Paradigm Press | Sponsored